Related Experiment Video
Updated: Apr 27, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
A registry on distal popliteal and infrapopliteal revascularization with coronary drug-eluting stents
Arturo Giordano1, Stefano Messina, Michele Polimeno
1aUnità Operativa di Interventistica Cardiovascolare, Presidio Ospedaliero Pineta Grande, Castelvolturno bUnità Operativa di Emodinamica, Casa di Salute Santa Lucia, San Giuseppe Vesuviano cDepartment of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.
Insights
Coronary drug-eluting stents (DESs) show promise for treating critical limb ischemia (CLI) in the popliteal and infrapopliteal arteries. This study found DES implantation feasible, safe, and effective in selected patients with focal lesions.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Endovascular Therapy
Background:
- Critical limb ischemia (CLI) due to popliteal and infrapopliteal artery disease presents significant challenges for endovascular treatment.
- Coronary balloon-expandable drug-eluting stents (DESs) have shown potential, but their risk-benefit profile in real-world CLI patients requires further evaluation.
Purpose of the Study:
- To assess the feasibility, safety, and effectiveness of coronary DES implantation for treating focal lesions in the distal popliteal and infrapopliteal arteries in patients with CLI.
- To evaluate the outcomes of DES use in this challenging patient population.
Main Methods:
- Retrospective analysis of institutional databases to identify patients undergoing DES implantation for distal popliteal or infrapopliteal artery disease.
- Systematic collection of baseline, lesion, procedural, and outcome data.
Main Results:
- Twenty-five patients with CLI were treated with coronary DES (sirolimus-eluting stents were most common).
- Significant improvement in Fontaine stage was observed at 1 month (92.0%) and long-term (88.0%).
- No repeat revascularizations or amputations occurred; two patients died late after the procedure.
Conclusions:
- Coronary balloon-expandable DES implantation is a feasible, safe, and effective option for selected patients with focal lesions in the distal popliteal and infrapopliteal arteries.
- This approach offers a promising solution for managing CLI in these challenging arterial segments.
Aims:
Endovascular therapy for popliteal and infrapopliteal artery disease in patients with critical limb ischemia (CLI) remains challenging, given the high risk of adverse events. Favorable results for coronary balloon-expandable drug-eluting stents (DESs) in this arterial district have been reported in selected studies, but uncertainty persists on their risk-benefit balance in real-world patients. We, thus, sought to appraise our outcomes with DES implantation for distal popliteal or infrapopliteal lesions.
Methods:
Our institutional databases were retrospectively queried to identify patients undergoing DES implantation for distal popliteal or infrapopliteal artery disease. Baseline, lesion, procedural, and outcome data were systematically collected.
Results:
A total of 25 patients were treated with coronary DES, 12 (48.0%) for distal popliteal and 13 (52.0%) for infrapopliteal lesions. Four (16.0%) patients received two stents, whereas the others only one. Breakdown of DES was as follows: biolimus-eluting, everolimus-eluting, paclitaxel-eluting, and sirolimus-eluting stents in, respectively, two (8.0%), one (4.0%), one (4.0%), and 21 (84.0%), with an average stent length of 33.6 ± 13.1 mm. Improvement in Fontaine stage was achieved in 23 (92.0%) patients at 1 month and in 22 (88.0%) patients at long-term (28.8 ± 20.6 months). In this highly selected case series, no repeat revascularizations or unplanned amputations were recorded, whereas two (8.0%) patients died, the first 15.5 months and the second 19.5 months after the procedure.
Conclusion:
Implantation of coronary balloon-expandable DES appears feasible, safe, and effective in selected patients with focal lesions in the distal popliteal and infrapopliteal arteries.
More Related Videos
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Acute Coronary Syndrome IV: Interprofessional Care